Cargando…

Assessment of humoral immune response to two mRNA SARS‐CoV‐2 vaccines (Moderna and Pfizer) in healthcare workers fully vaccinated with and without a history of previous infection

AIMS: Presence of anti‐S1 region of SARS‐CoV‐2 spike protein was analysed, at two and eight months, in 477 immunocompetent healthcare workers in Zaragoza, Spain, vaccinated with mRNA‐1273 (Moderna) or BNT162b2 (Pfizer). METHODS AND RESULTS: Antibody analysis was performed with Alinity i System (Abbo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serrano, Laura, Algarate, Sonia, Herrero‐Cortina, Beatriz, Bueno, Jessica, González‐Barriga, María T., Ducons, María, Montero‐Marco, Jesica, Acha, Beatriz, Taboada, Ana, Sanz‐Burillo, Pilar, Yuste, Cristina, Benito, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350023/ https://www.ncbi.nlm.nih.gov/pubmed/35801660 http://dx.doi.org/10.1111/jam.15699

Ejemplares similares

Persistence of Anti-S1 IgG against SARS-CoV-2 Eight Months after the Booster Dose of Vaccine in Naive and Previously Infected Healthcare Workers
por: Algarate, Sonia, et al.
Publicado: (2023)

Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)

Disparity in Public Perception of Pfizer and Moderna COVID-19 Vaccines on TikTok
por: Baumel, Nicholas M., et al.
Publicado: (2022)

Methodological Analysis: Randomized Controlled Trials for Pfizer and Moderna COVID-19 Vaccines
por: Hallas, Donna, et al.
Publicado: (2021)

Usefulness of Non-Skin Samples in the PCR Diagnosis of Mpox (Monkeypox)
por: Algarate, Sonia, et al.
Publicado: (2023)

Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines
por: Xia, Xuhua
Publicado: (2021)

Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
por: Patyna, Sammy, et al.
Publicado: (2022)

A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
por: Patel, Rikin, et al.
Publicado: (2022)

Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation
por: Yoshikawa, Takeharu, et al.
Publicado: (2022)

Pregnancy outcomes in persons receiving pfizer versus moderna COVID-19 vaccines in the United States
por: Darwin, Kristin C., et al.
Publicado: (2023)

Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
por: Islam, Nazmul, et al.
Publicado: (2022)

Selection Effects and COVID-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records
por: Atanasov, Vladimir, et al.
Publicado: (2023)

Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review
por: Reynolds, Lia, et al.
Publicado: (2023)

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022)

Developmental Status of the Potential Vaccines for the Mitigation of the COVID-19 Pandemic and a Focus on the Effectiveness of the Pfizer-BioNTech and Moderna mRNA Vaccines
por: Noor, Rashed
Publicado: (2021)

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases
por: McMahon, Devon E., et al.
Publicado: (2021)

How exciting is the Pfizer vaccine?
por: Lawton, Graham
Publicado: (2020)

COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers
por: Famuyiro, Tolulope B., et al.
Publicado: (2021)

The Effect of Third Dose of Pfizer/BioNTech and Moderna COVID-19 mRNA Vaccines on IgG Antibody Titers
por: Khuc, Thao A, et al.
Publicado: (2023)

Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
por: Tuong, Linh-An C, et al.
Publicado: (2021)

Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate
por: Hermosilla, Jesús, et al.
Publicado: (2023)

Flowserve supports Pfizer in vaccine production
Publicado: (2021)

Pfizer: The miracle vaccine for COVID-19?
por: Badiani, A.A., et al.
Publicado: (2020)

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021
por: Pilishvili, Tamara, et al.
Publicado: (2021)

SARS-CoV-2 infection in fully vaccinated healthcare workers
por: Hernández Porto, Miriam, et al.
Publicado: (2022)

Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
por: Haq, Hannah N., et al.
Publicado: (2022)

The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine
por: Farias, Jessica Pires, et al.
Publicado: (2022)

Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2021)

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2022)

Comparison of BNT162b2 (Pfizer–BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients
por: Kaiser, Robert A., et al.
Publicado: (2021)

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
por: Tenforde, Mark W., et al.
Publicado: (2021)

Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database
por: Tobaiqy, Mansour, et al.
Publicado: (2021)

Moderna Vaccine Induced Recurrent Myopericarditis
por: Arasaratnam, K.
Publicado: (2022)

Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review
por: Cortés-Sarabia, Karen, et al.
Publicado: (2022)

Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older
por: Saiag, Esther, et al.
Publicado: (2023)

Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system
por: Ioannou, George N., et al.
Publicado: (2022)

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
por: Tenforde, Mark W., et al.
Publicado: (2021)

MYOCARDITIS LINKED TO PFIZER-BIONTECH COVID-19 VACCINE
por: PRATAP SINGH, VIJAY, et al.
Publicado: (2021)

First Case of Erythema Nodosum Associated With Pfizer Vaccine
por: Aly, Mohammed H, et al.
Publicado: (2021)

Symptomatic Myocarditis After Pfizer Covid-19 Vaccination
por: Patel, Kirtan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ekfrrh9l2hmjodib1cvc92hv3i